A new study may have just given brain surgeons a significantly better way to fight cancer without compromising how patients live afterward. Published in Science Advances, the research unlocks a layer of information already sitting in the operating room, one that surgeons have never had the tools to interpret until now.
Awake brain mapping has anchored neurosurgical practice for generations. The procedure keeps patients conscious while surgeons deliver precise electrical pulses to targeted brain regions, monitoring responses to verbal tasks as they operate. Accurate, timely answers indicate a region is safe to remove, while hesitation or speech failure signals the opposite, and because the brain carries no pain-sensing nerves, patients feel none of it.
The central discovery involves what happens between obvious successes and obvious failures. Carnegie Mellon University cognitive neuroscientist Bradford Mahon, who directed the research, found that analyzing both mistake patterns and reaction times on successful responses generates a considerably more detailed map of how language functions in each individual brain. His team also established that precise electrical characteristics of each stimulation pulse correlate with minute behavioral variations that the field had never formally measured before.
Psycholinguist and lead author Raouf Belkhir says the conventional framework treats stimulation as strictly yes or no. He argues the truth is far more graduated. Electrical stimulation might produce reliable errors, no discernible effect, or a slight drag on response speed that falls short of outright failure. That zone between clear outcomes, Belkhir says, frequently carries the most surgically relevant data.
Understanding those gradations matters enormously because no two brains are identical. Mahon uses a striking illustration to make the point: an accountant might willingly trade some physical dexterity to preserve full verbal function, while a professional musician might prioritize the opposite. When surgical teams can model likely outcomes against individual priorities beforehand, patients gain genuine input into what the procedure fights to preserve.
MindTrace, a platform that grew out of Mahon’s CMU research group, seeks to deliver that capability. Drawing together assessment data from every stage of a patient’s surgical journey, it feeds a live information stream that updates throughout the operation. Six American hospitals are currently pooling outcome records to develop predictive models for future procedures.
University of Rochester neurosurgeon Tyler Schmidt has used MindTrace in over ten operations this year and says it gives his team a coherent, real-time picture that sharpens decision-making at every stage.
Schmidt says the ambitions of brain tumor surgery have been genuinely transformed. Where surgeons once asked simply whether safe removal was possible at all, the question has become which specific capacities matter most to each patient, and how to preserve them while reaching the same medical destination. That shift, he says, represents a fundamentally better standard of care.
Once surgery is successfully completed using this brain mapping approach, medications like those being developed by pharmaceutical companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) can then treat any residual cancer tissues.
About TinyGems
TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.TinyGems.com
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer
TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
Editor@TinyGems.com
TinyGems is powered by IBN
Frontieras is developing breakthrough technologies that convert abundant solid hydrocarbons such as coal into cleaner…
LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers…
The National Transportation Safety Board (“NTSB”) has intensified its focus on collision-prevention technologies following multiple…
LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhance the effectiveness…
Jack Dorsey is making a concrete bet that artificial intelligence can replace what middle managers have…
Scientists have overcome production barriers that have plagued doxorubicin manufacturing since the 1970s by engineering…